Cite
HARVARD Citation
Kremastiotis, G. et al. (n.d.). The proteasome inhibitor carfilzomib (Cfz) induces cardiotoxicity in vivo: molecular mechanisms and the cardioprotective effect of metformin (Met). Journal of molecular and cellular cardiology. pp. 33-. [Online].